Key Findings:  This study demonstrates that THC and CBD, alone and synergistically, attenuate inflammation and motility disturbances in a rat model of colitis, with additive and potentiating effects that protect enteric cholinergic nerves and suggest therapeutic benefit for inflammatory bowel disease.
Type of Study:  Animal Study
Study Sample Size:  85
Study Result:  Positive
Research Location(s):  United Kingdom
Year of Pub:  2026
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Not Applicable
Route of Administration:  , Injection
Citation:  Jamontt JM, Molleman A, Pertwee RG, Parsons ME. The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. Br J Pharmacol. 2010 Jun;160(3):712-23. doi: 10.1111/j.1476-5381.2010.00791.x. PMID: 20590574; PMCID: PMC2931570.